Fast Track designation News
Most Popular Fast Track designation Story
FDA fast-tracks ARCA's Gencaro
ARCA Biopharma said U.S. health regulators have granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending its shares up as much as 81 percent. Report Read more...
Latest Headlines
- April 6, 2010
- November 24, 2009
- August 25, 2009
- June 18, 2009
- May 22, 2009
- May 9, 2008
- March 25, 2008
- March 18, 2008
- December 3, 2007
- December 3, 2007
- July 20, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
